Skip to search formSkip to main contentSkip to account menu

Ursofalk

Known as: Tramedico Brand of Ursodeoxycholic Acid, Provalis Brand of Ursodeoxycholic Acid, Orphan Brand of Ursodeoxycholic Acid 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

UrsodeoxycholateUrsodiol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Effects of Combined Treatment with Transmentil and Ursofalk on Liver Function and Perinatal Prognosis in Pregnant Women with Intrahepatic Cholestasis of Pregnancy
Objective: To analyze the effects of combined treatment with Transmentil and Ursofalk on liver function and perinatal prognosis… 
2018
2018
Issues of therapy for biliary pathology in children: the choice of the optimal solution
Background. Diseases of the hepatobiliary system are one of the most important problems of pediatric gastroentero­logy. Lesions… 
2016
2016
Patho-physiological studies on the Reverse Effect of Curcumin (Curcuma longa, Zingiberaceae) and Ursofalk (Ursodeoxycholic acid) against the Toxicity of Carbon Tetrachloride on Albino Rats
This study, was established five groups of albino rats to determine the therapeutic effect of Curcuma longa and ursofalk against… 
2006
2006
Dysfunction and correction of microsomal enzyme oxidation, glucuronidation and glutathione conjugation of xenobiotics in the liver of deoxycholate-intoxicated rats
Intoxication with deoxycholic acid is accompanied by destruction of hepatocyte plasma membrane (increased serum alanine… 
2006
2006
Clinical study of ursofalk and prostaglandin E1 on hepatic cirrhosis
Objective To observe the efficacy and safety of prostaglandin E1(PGE1) and ursofalk(UDCA) in remaining hyperbilirubinem of… 
2005
2005
Bioequivalence of a new liquid formulation of ursodeoxycholic acid (Ursofalk suspension) and Ursofalk capsules measured by plasma pharmacokinetics and biliary enrichment
Background:  Ursodeoxycholic acid is an approved therapy for hepatobiliary disorders but in infants and children compliance is… 
2000
2000
[Treatment of primary biliary cirrhosis with ursodeoxycholic acid].
This study was undertaken to evaluate the efficacy of ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis… 
1997
1997
Studies on the effect of ursodesoxycholic acid on rats with acute carbontetrachloride injury.
Bilirubin is a sensitive marker of toxic liver injury. Carbontetrachloride (CCl4) is used in some manufactures and laboratories… 
1992
1992
Clinical evidence of hepatoprotection induced by ursodeoxycholic acid.
Ursodeoxycholic-acid (UDCA) was introduced to the clinical practice as an effective agent for the dissolution of gallstones. The… 
1991
1991
Does ursodeoxycholic acid(UDCA) improve the prognosis of primary biliary cirrhosis(PBC)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)